Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia

Social Phobia Clinical Trial

Official title:

Social Phobia: Assessment and Treatment of Social Skills

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00073333
• Other study ID #: R01MH062547
• Secondary ID: R01MH062547
• Status: Completed
• Phase: N/A
• First received: November 19, 2003
• Last updated: July 1, 2013
• Start date: December 2002
• Est. completion date: March 2008

Study information

• Verified date: July 2013
• Source: Milton S. Hershey Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This study will determine whether people with social phobia are deficient in certain social skills.

Description:

Social phobia is a debilitating condition that can cause severe social, emotional, educational, and occupational functioning problems. Evidence suggests that individuals with social phobia are deficient in social skills, but the exact skills deficits have not been elucidated. This study will comprise two substudies: one will examine social skills deficits in social phobics and determine how they differ from those of people without social phobia; the other will determine if skills deficits in social phobics can be improved and whether improvements will affect overall social functioning.

Participants in this study will be randomly assigned to one of three groups for 16 weeks: an exposure group, a social skills training and exposure (SET) group, or a wait-list control group. Interviews, self-reports, and simulated role plays will be used to assess the social skills of participants.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 379
• Est. completion date: March 2008
• Est. primary completion date: March 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of Social Phobia

Exclusion Criteria:

• Axis II diagnosis of schizoid or schizotypal personality disorder or paranoia

• Axis II diagnosis of mental retardation, obsessive-compulsive disorder, and personality disorders, except for avoidant personality disorder

• Instability on any antidepressants

• Psychotic disorder

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Phobic Disorders
• Social Phobia

Intervention

Behavioral:
• Social Skills Training
Social skills training once per week
• Exposure Treatment
Exposure once per week
• Placebo
Placebo

Locations

Country	Name	City	State
United States	Penn State Milton S. Hershey Medical Center	Hershey	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
Milton S. Hershey Medical Center	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Social Phobia Remission		Measured at Month 12	No
Primary	Social Phobia Remission Rate at 6 Month Follow-up	Lack of SocialPhobia Diagnosis at 6 month follow-up	6 month follow up	No
Secondary	Score on the SPAI		Measured at Month 12	No